Express Scripts Indication-Based Contracts For Inflammatory Drugs Begin In 2017
Program may provide drugs with narrower labels an opportunity to gain preferred formulary status versus entrenched market leaders.
Program may provide drugs with narrower labels an opportunity to gain preferred formulary status versus entrenched market leaders.